Scientists track common painkiller inside brain tumors
NCT ID NCT04716699
Summary
This small, early-stage study measured how much of the common painkiller lidocaine gets into brain tumors during surgery. Researchers took blood and tumor samples from 12 glioblastoma patients to understand how the drug moves through the body and tumor. The goal was to gather basic information that might help design future treatments, not to test a new therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.